These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8752570)

  • 1. [The interferon treatment of hepatitis C in the liver transplant patient].
    de la Mata M; Fraga E; Miño G
    Gastroenterol Hepatol; 1996 May; 19(5):259-61. PubMed ID: 8752570
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia.
    Sohara N; Takagi H; Kakizaki S; Sato K; Mori M
    Transpl Int; 2006 Mar; 19(3):255-7. PubMed ID: 16441778
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C: ribavirin and/or interferon?
    Heathcote J
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S71-5. PubMed ID: 8986103
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon and other therapies for hepatitis B and hepatitis C infections.
    Rothstein KD; Munoz SJ
    Clin Lab Med; 1996 Jun; 16(2):465-91. PubMed ID: 8792083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
    Smallwood GA; Devine R; Fasola C; Stieber AC; Heffron TG
    Transplantation; 2008 Dec; 86(12):1795-8. PubMed ID: 19104424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The course of hepatitis C infection after liver transplantation].
    Ołdakowska-Jedynak U; Paczek L
    Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon treatment of cirrhotic patients with chronic hepatitis C: a logical intervention.
    Davis GL
    Am J Gastroenterol; 1994 May; 89(5):658-60. PubMed ID: 7513491
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C, interferon, and risk of rejection after liver transplantation.
    Samuel D
    Liver Transpl; 2004 Jul; 10(7):868-71. PubMed ID: 15237370
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. Hepatitis/HIV Spanish Study Group.
    Soriano V; Bravo R; García-Samaniego J; Castilla J; González J; Castro A; Llibre JM
    AIDS; 1997 Mar; 11(3):400-1. PubMed ID: 9147443
    [No Abstract]   [Full Text] [Related]  

  • 11. Course and treatment of recurrent Hepatitis C after liver transplantation.
    Neumann UP; Neuhaus P
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):61-6. PubMed ID: 15719007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR; Burton JR; Villamil F; Rosen HR
    Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific hyporesponsiveness in ELISPOT assay is associated with early recurrence of hepatitis C in liver transplant recipients.
    Tambur AR; Ben-Ari Z; Herrera ND; Klein T; Michowiz R; Mor E
    Hum Immunol; 2005 Jan; 66(1):21-7. PubMed ID: 15620458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation.
    Kishi Y; Sugawara Y; Akamatsu N; Kaneko J; Tamura S; Kokudo N; Makuuchi M
    Clin Transplant; 2005 Dec; 19(6):769-72. PubMed ID: 16313323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hepatitis type C co-infected with GBV-C treated with interferon.
    Suzuki H; Sata M; Noguchi S; Uchimura Y; Tanikawa K
    Am J Gastroenterol; 1996 Dec; 91(12):2651-2. PubMed ID: 8947017
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hepatitis C after liver transplantation.
    Berenguer M
    Clin Liver Dis; 2005 Nov; 9(4):579-600, vi. PubMed ID: 16207565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of hepatitis C after liver transplantation.
    Friman S
    Transplant Proc; 2005 Oct; 37(8):3311-2. PubMed ID: 16298582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of alcoholic liver disease and hepatitis C.
    Marsano LS; Peña LR
    Hepatogastroenterology; 1998; 45(20):331-9. PubMed ID: 9638402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse response to interferon and ribavirin in liver transplant recipient with hepatitis C recurrence.
    Coccoli P; Cordone G; Bruno M; Parrilli G
    Transplant Proc; 2005 Dec; 37(10):4406-7. PubMed ID: 16387132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for hepatitis C.
    Marubashi S; Dono K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
    J Hepatobiliary Pancreat Surg; 2006; 13(5):382-92. PubMed ID: 17013711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.